Trials / Terminated
TerminatedNCT02393716
Endurant Evo US Clinical Trial
- Status
- Terminated
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 139 (actual)
- Sponsor
- Medtronic Cardiovascular · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to demonstrate that the Endurant Evo Abdominal Aortic Aneurysm (AAA) stent graft system is safe and effective for endovascular treatment of infrarenal abdominal aortic or aortoiliac aneurysms.
Detailed description
The clinical evidence collected as part of this trial will be used in conjunction with data collected during the concurrently enrolling Endurant Evo International Clinical Trial.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Endurant Evo AAA Stent Graft System | |
| PROCEDURE | Endovascular aneurysm repair (EVAR) |
Timeline
- Start date
- 2015-04-01
- Primary completion
- 2021-06-25
- Completion
- 2021-06-25
- First posted
- 2015-03-19
- Last updated
- 2022-12-06
- Results posted
- 2022-12-06
Locations
14 sites across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT02393716. Inclusion in this directory is not an endorsement.